Skip to main content
. 2021 Nov 30;70(Suppl 1):S69–S78. doi: 10.33549/physiolres.934776

Table 3.

Characteristics of Crohn’s disease (CD) and fertility parameters according to AMH

AMH≥1.77 ug/l, n=31 AMH<1.77 ug/l, n=19 P value
median [25–75P] or n (%)
Age, y 29.00 [25.50, 32.00] 39.00 [33.50, 42.00] <0.001
Body mass index, kg/m 2 20.20 [19.00, 21.62] 21.62 [20.47, 23.14] 0.122
Smoking, n (%) 9 (29.0) 7 (38.9) 0.537
Age of CD dg, y 22.00 [17.50, 25.00] 27.00 [24.00, 31.00] 0.002
CD duration, y 8.00 [4.00, 11.00] 10.00 [4.50, 14.00] 0.217
CD dg. <5 years, n (%) 13 (41.9) 6 (31.6) 0.556
CD phenotype *
B1, n (%) 17 (54.8) 10 (52.6) 1.000
B2, n (%) 10 (32.3) 4 (21.1) 0.522
B3, n (%) 4 (12.9) 5 (26.3) 0.273
L1, n (%) 17 (54.8) 7 (36.8) 0.255
L2, n (%) 3 (9.7) 6 (31.6) 0.067
L3, n (%) 11 (35.5) 6 (31.6) 1.000
Serum creatinine, umol/l 56.30 [50.70, 61.00] 62.10 [56.05, 65.70] 0.089
Disease activity
Quality of life score (SIBDQ) 59.00 [46.00, 67.00] 64.00 [52.75, 67.50] 0.398
Harvey-Bradshaw index 2.00 [0.00, 4.50] 0.00 [0.00, 2.00] 0.115
Stool calprotectin, ug/g 69.10 [43.23, 190.25] 64.00 [15.25, 153.00] 0.424
C-reactive protein, mg/l 2.08 [0.92, 7.95] 2.00 [0.38, 2.80] 0.232
White blood cells, ×10.9/l 7.84 [5.97, 9.56] 6.91 [5.72, 8.82] 0.602
Therapy 2 (6.7) 0 (0.0)
steroids, n (%) 2 (6.7) 0 (0.0) 0.528
aminosalicylates, n (%) 18 (58.1) 12 (63.2) 0.774
azathioprine, n (%) 19 (61.3) 10 (52.6) 0.570
anti-TNF alpha, n (%) 18 (58.1) 12 (63.2) 0.774
anti-TNF alpha ever, n (%) 22 (73.3) 12 (70.6) 1.000
IBD surgery, n (%) 12 (38.7) 8 (42.1) 1.000
Reproductive health
Irregular menstrual cycle, n (%) 10 (32.3) 4 (23.5) 0.741
Hirsutism, n (%) 2 (6.9) 2 (11.8) 0.619
Spontaneous abortion, n (%) 0 (0.0) 3 (16.7) 0.062
At-risk pregnancy, n (%) 0 (0.0) 3 (17.6) 0.095
Preterm delivery, n (%) 1 (5.6) 2 (11.8) 0.603
Induced abortion, n (%) 2 (7.7) 4 (22.2) 0.208
Deliveries, n 0.00 [0.00, 1.00] 1.00 [1.00, 1.50] 0.016
0, n (%) 18 (58.1) 4 (21.1) 0.043
1, n (%) 9 (29.0) 10 (52.6)
2, n (%) 4 (12.9) 5 (26.3)
Gynecological surgery, n (%) 5 (17.2) 6 (33.3) 0.291
Contraception, n (%) 6 (19.4) 1 (5.9) 0.396
In-vitro fertilization, n (%) 0 (0.0) 0 (0.0) 1.000
*

Vienna classification: Localisation: L1 terminal ileum, L2 colon, L3 ileocolon, Behavior: B1 inflammatory, B2 stricturizing, B3 penetrating